Profound Medical Corp.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-9.5M | $-7.1M | $-8.2M | $-8.0M | $-15.7M | $-10.7M | $-4.9M | $-9.4M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $126.0K | $93.0K | $62.0K | $93.0K | $102.0K | $116.0K | $160.0K | $164.0K |
| Amortization | $9.0K | $7.0K | $47.0K | $54.0K | $39.0K | $47.0K | $78.0K | $50.0K |
| Stock-Based Compensation | $874.0K | $1.0M | $1.4M | $1.7M | $1.5M | $989.0K | $442.0K | $604.0K |
| Net Cash from Operating Activities | $-11.3M | $-8.6M | $-6.6M | $-9.6M | $-13.7M | $-8.3M | $-5.9M | $-6.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | — | $41.4M | $0 | $0 | $-290.0K | $35.4M | $-592.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — | — | — | — |